Multicell Techs Inc (MCET)

OTC Markets
0.00000
0.00000(0.00%)
  • वॉल्यूम:
    0
  • बोली/पुछे:
    0.00000/0.00000
  • दिन की रेंज:
    0.00000 - 0.00000

MCET समीक्षा

पिछला बंद
-
दिन की रेंज
-
आय
-
खुला
-
52 सप्ताह रेंज
0-0.001
ईपीएस
0
वॉल्यूम
0
मार्केट कैप
5K
लाभांश (यील्ड)
N/A
(N/A)
औसत वॉल्यूम (3एम)
634,298
पी/ई अनुपात
-0.019
बीटा
-13.38
1- वर्ष बदलाव
-75%
बकाया शेयर
5,000,988,700
अगली कमाई तिथि
18 अक्तू॰ 2022
Multicell Techs Inc पर आपकी भावना क्या है?
या
समुदाय परिणामों को देखने के लिए वोट करें!

Multicell Techs Inc कंपनी प्रोफाइल

Multicell Techs Inc कंपनी प्रोफाइल

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

और पढ़ें

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजमजबूत खरीदमजबूत खरीदमजबूत विक्रयमजबूत विक्रयमजबूत विक्रय
तकनीकी संकेतकतटस्थखरीदेंतटस्थतटस्थमजबूत विक्रय
सारांशखरीदेंमजबूत खरीदबेचनाबेचनामजबूत विक्रय